Glycosphingolipids in diabetes, oxidative stress, and cardiovascular disease: prevention in experimental animal models

HIGHLIGHTS

  • who: Amrita Balram and colleagues from the Department of Pediatrics, Cardiology Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA have published the paper: Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models, in the Journal: (JOURNAL) of 28/Nov/2022
  • what: An important aspect of this study was to examine the effects of lowering GSL levels on genes involved in antioxidant defense.
  • future: To further understand the complexities in T2D and to develop drugs a systemsbased biology approach is needed that could integrate molecular markers including sphingolipids . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?